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ABSTRACT

Objective. To assess the feasibility of implementing a physician-based, patient-centered
counseling intervention model in Ecuador to improve the ability of primary care physicians
(PCPs) to reduce cardiovascular disease (CVD) risk factors among patients.
Methods. This was a randomized clinical trial conducted in primary care clinics in
Quito in 2014 – 2016. Participants included 15 PCPs and their adult patients at high risk
of developing type-2 diabetes. A physician-based and patient-centered counseling program
was delivered to eight PCPs. Seven PCPs who did not receive the training comprised the
control group. The patient experience was assessed by a patient exit interview (PEI).
Assessment of the patient’s anthropometrics, blood pressure, and blood biochemistry parameters were conducted. Changes within and between groups were estimated utilizing chisquare, ANOVA, paired t-tests, and coefficient with intervention.
Results. A total of 197 patients participated, 113 in the intervention care group (ICG) and
84 in the usual care group (UCG); 99 patients (87.6%) in the ICG and 63 (75%) in the UCG
completed the study. Counseling steps, measured by the PEI, were significantly higher in the
ICG (8.9±1.6 versus 6.6±2.3; P = 0.001). Comparison of the estimated difference between the
ICG and the UCG showed greater decreases in HbA1c and total cholesterol in the ICG. Within
the ICG, there were significant improvements in weight, BMI, HbA1C, total cholesterol, and
LDL-cholesterol.
Conclusions. Training PCPs in a patient-centered behavioral intervention for CVD risk
factor reduction is feasible and efficacious for reducing CVD risk factors in Ecuador. Developed
and developing countries alike could benefit from such an intervention.
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Overweight and obesity are public
health problems worldwide. Middle-
income countries, such as Ecuador, are simultaneously experiencing the presence
of both deficient and excess nutrition (1).
It has been estimated that in developing
countries, excess nutrition and diseases
associated with it can have a greater
negative impact on morbidity and mortality than in developed countries (2). In recent decades, the leading causes of death
in Ecuador have included cardiovascular disease (CVD), type 2 diabetes, and
hypertension (3).
In 2013, the Ministry of Public Health
of Ecuador published the National Health
and Nutrition Examination Survey. The
results indicated that 62.8% of the adult
population is overweight or obese (4) and
that the prevalence of CVD risk factors is
increasing. In addition, among adults
over 50 years of age, approximately half
are dyslipidemic, 22.7% have hypertension, 10.3% have diabetes, and 57.2%
smoke cigarettes. Other metabolic conditions associated with CVD are also
common in adults; prevalence rates of

metabolic syndrome (27.7%) are higher
than those reported for the adult population of the United States (22.0%) in 2010.
The same survey also indicated that 45%
of adults are sedentary and that medication adherence is poor (48.9% reported
not taking their medication). Moreover,
type 2 diabetes, the primary cause of
death in Ecuador, is a major risk factor for
CVD (3).
According to the World Health Organization’s Alma-Ata principles, primary care should be a cornerstone of
patient health care (5). Therefore, it is
necessary to implement intervention
strategies that help primary care physicians (PCPs) and health care systems to
decrease the prevalence of CVD risk
factors in Ecuador. Intervention strategies to decrease CVD risk factors need
to consider the local context, including
the characteristics of national health
care systems and the knowledge and attitudes of patients (6).
Previous work in the United States
among Latino populations has demonstrated the effectiveness of an intervention model using physician-delivered,
patient-centered counseling within a supportive office environment to decrease
CVD risk factors (7). That study showed
that brief patient-centered nutrition
counseling delivered by physicians combined with office support can produce
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beneficial changes in patient diet, weight,
and blood lipid concentrations.
Consequently, the objective of the
present study was to assess the feasibility of implementing a physician-based,
patient-centered counseling intervention
model in Ecuador to improve the ability
of PCPs to reduce CVD risk factors
among their patients.

MATERIALS AND METHODS
Clinical sites selection
Clinical system networks in Quito
were selected based on their willingness
to participate; provision of care to large,
middle- and low-income populations;
and the availability of electronic medical records. Six health care systems that
met these criteria were invited to participate; four accepted: two private, one
public, and one private/public. For the
intervention care group (ICG), one public and two private clinics from these
health systems were randomly selected.
In these, the PCPs were trained on patient-centered counseling methods and
received office system prompts for delivering the intervention. For the usual
care group (UCG), one private, one public, and one private/public clinic were
randomly selected. In these, PCPs continued their usual practice. Primary care
physicians and internists that were
regularly working in the clinics were invited to participate. A total of 15 physicians participated, eight in the ICG and
seven in the UCG.

Training on nutrition, physical
activity, and statin use
Training of physicians in the ICG
included an intensive 4-hour session
comprising a didactic component on the
relationship between behavior and CVD
risk factors and a review of the guidelines for statin therapy. Physicians received a training binder with copies of
the lecture slides, the counseling intervention algorithms, a sample counseling
script, and other intervention materials
(diet and exercise goal sheets, the Diet
and Physical Activity Risk Assessment
[DARA] guide, and the statin use algorithm, patient education materials, and
a step counter). Subsequently, physicians
were introduced to patient-centered
counseling, its algorithms, and the statin
use algorithm per the current guidelines

for the United States (8, 9). Since there are
no local guidelines for statin use, most
physicians follow the United States or
European guidelines. Physicians in the
ICG were also taught to implement a
7 – 10-minute patient-centered counseling protocol that included information
on the benefits of walking and other easy
physical activities, as well as dietary
counseling, particularly reducing the
consumption of simple carbohydrates,
saturated fat, and salt, and increasing
consumption of fruits and vegetables.
To evaluate the physicians’ changes in
attitudes and knowledge on physical activity, diet, and lipid therapy, and any
improvements in counseling skills, preand post-training assessments using a
previously validated instrument were
conducted among the ICG (7). Physicians were taught to use the office support materials with their patients through
live examples followed by role-playing
with fellow PCPs who alternating roles
as clinician, patient, and observer. Further practical reinforcement training was
carried out by a member of the research
team in the physicians’ offices.
During the 6 months of the study, physicians in the ICG delivered the interventions using a package affixed to each
study patient’s chart. The office support
included a folder containing: the patient’s
most recent lipid levels with a prompt
highlighting the direct low density
lipoprotein cholesterol (LDL-C) value, a
completed DARA questionnaire (for the
initial visit only), DARA guide, dietary
goal sheets to use with the patient, the
counseling algorithm, and a copy of the
national cholesterol management guidelines. Clinic personnel, along with the
support of the research team, tracked
patients due for visits.

Pre-eligibility and patient selection
Study participants were selected using
the clinic’s patient appointment database.
A recruitment call list was generated as
needed, screening for patient age and
body mass index (BMI) criteria (age ≥
30 years and BMI ≥ 25). Those identified
received a pre-screening recruitment by
telephone to verify age, BMI, and statins
use. Patients taking lipid-lowering medications, those with known coronary heart
disease, and those with secondary causes
of hyperlipidemia were excluded.
Members of the research team made the
pre-eligibility screening telephone calls.

Rev Panam Salud Publica 42, 2018

Baldeón et al. • Training to reduce cardiovascular risk factors in Ecuador

When a pre-eligible patient showed interest in participating, a fasting screening
appointment was scheduled. Participants that accepted screening received a
study identification code and were registered in the tracking database.

Screening assessment
The day before the screening appointment, participants were reminded of the
visit and the required overnight fasting.
At the appointment, research staff verified the patient’s eligibility and obtained
their informed consent. A venous blood
sample was taken to measure: glucose
and a complete lipid profile (total cholesterol [Total-C]; direct LDL-C, high density lipoprotein cholesterol [HDL-C]; and
triglycerides). Height and weight were
measured with light clothing and no
shoes. Blood pressure was measured after 10 minutes of rest. The clinic coordinator then calculated the risk of developing
type 2 diabetes using the Stern formula
(10), notifying each patient of their eligibility and sharing the laboratory results
with their physician.
Eligible patients were scheduled to return for a baseline physician visit. Prior to
the baseline visit, the coordinator asked
the clinical laboratory to complete the
determinations of glycated hemoglobin

(HbA1c), AST, and ALT, and to store serum samples for insulin determinations.
All insulin samples were assayed in a single batch at the end of the study.

Baseline visit with a physician
Twenty-four hours before the baseline
appointment, patients were reminded
of the visit. Before the physician’s consultation, each participant provided a
definitive informed consent. The clinic
coordinator administered the DARA
questionnaire, which was used for the
physician’s counseling with each patient.
Patients also completed a baseline survey that included sociodemographic
information, diet and physical activity,
family history of chronic diseases, and
use of alcohol. Within the diet section,
there were 10 questions regarding consumption of fruits and vegetables, and 17
questions related to fat consumption. To
quantify fat and fruits/vegetables consumption, a score was applied based on
previous studies (7). Finally, the research
staff administered a depression screening to each participant using the Center
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for Epidemiologic Studies Depression
Scale (11, 12). A score ≥ 16 was reported
to the patient’s physician since it indicates being at high risk for depression.
Appointments with the physician
lasted approximately 20 minutes. After
this baseline visit, patients were met by
a research staff member who administered the “Patient Exit Interview” (PEI)
to evaluate how well the physician had
followed the 12 patient-centered counseling steps (7).

6-month assessment visit
The clinic coordinator scheduled a
30-minute appointment 6 months after
the baseline clinical visit and reminded
each patient to fast overnight before the
visit. The day of the appointment, the
clinic coordinator administered the same
assessment instruments as in the baseline visit, except for the DARA. The patient’s weight and blood pressure were
measured. A question regarding medication compliance was included in the final
survey; it asked for the number of days
per week that the patient complied with
prescribed medication. A blood sample
was also obtained to determine the same
biochemical parameters measured at
baseline. Patients received a US$ 6 incentive after each study visit.

Anthropometric measurements
Anthropometric measurements were
taken at the baseline visit and at the
6-month follow-up visit. Weight and
height were recorded by trained staff
using standardized techniques and calibrated equipment (13). For weight measurement, an electronic SECA® 213 scale
(Seca GmbH & Co., Hamburg, Germany); for height measurement, a vertically-mounted SECA® 213 stadiometer
was used. Height was measured to the
nearest 1.0 cm.

Blood samples
Qualified staff obtained venous blood
samples from patients in the morning
(after overnight fasting). Samples
(plasma and serum) were centrifuged
within 2 hours and processed immediately, except for insulin, which was measured in all samples at the end of the
study p
 eriod. Each patient was assigned
a unique bar-code identification to accurately trace samples (4).

Original research

Glucose, lipid profile, glycated
hemoglobin, and insulin
measurements
Blood glucose, total-C, direct LDL-C,
HDL-C, and triglycerides were determined on a COBAS 6000-E601
(Hitachi High-Technologies Corporation
/ Minati-ku, Tokyo, Japan) using standard reagents (Roche Diagnostics GmbH,
Mannheim, Germany). Serum insulin
was determined using an electro-chemiluminescence immunoassay following
the manufacturer’s instructions (Roche
Diagnostics GmbH, Mannheim, Germany) and chemiluminescent emission
was measured using a fully automated
analyzer system, the COBAS 6000 E601.
Glycated hemoglobin was determined
by immunoturbimetry/Acs anti-HbA1c,
using the COBAS 6000 E601 according to
the manufacturer’s instructions. Blood
biochemistry analyses were conducted at
NetLab (Quito, Ecuador), a laboratory
certified by the College of American Pathologists and the Brazilian Society of
Clinical Pathologists (14).
To calculate the homeostasis model
assessment-estimated insulin resistance
(HOMA), the study utilized a modified
formula by Wallace and colleagues—
fasting plasma glucose (mg/dL) multiplied by fasting serum insulin (mU/ml),
divided by 405 (14).

Ethics
The Institutional Review Boards of
the University of Massachusetts Medical
School (Worcester, Massachusetts, United
States) and Universidad de Las Américas
(Quito, Ecuador) approved the study each
year. The study followed the ethical standards of the Declaration of Helsinki (15).

Statistical analyses
Sample size was estimated by considering PEI scores with a standard deviation
(SD) obtained by the authors from previous studies among a Latino population in
Massachusetts, United States. A PEI score
difference of 2 points±2.9 was used.
Considering this study’s design and an
estimated intra-cluster correlation value
for PEI of 0.3 per the Worcester Area
Trial for Counseling in Hyperlipidemia
(WATCH) study (7), a sample of 200 subjects provided 84% power; thus, patients
were assigned to each of the two study
groups at a ratio of 1:1.
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Descriptive statistics were calculated
for continuous variables; frequencies and
percentages were calculated for categorical variables. Analyses were performed
with intention to treat. Differences between groups were assessed with chisquare test and ANOVA. Differences
within groups were assessed with paired
t-test or the corresponding non-parametric statistics. Coefficient with intervention, which is the estimated difference
between the ICG and the UCG according
to the change in the measured biochemical parameter, was calculated. Adjusted
analyses were carried out that accounted
for the patient clustering within physicians at the individual sites (to account
for correlations of patients treated by individual physicians).
Mean differences between the ICG and
the UCG for PEI score, anthropometric
and blood pressure measures, and blood
biochemistry parameters were estimated
and tested using mixed effects linear regression models with physician as a random effect. This is a method suggested by
Donner and Klar (16). Statistical analyses
were performed with SAS® v9.4 software
(Armonk, New York, United States).
Descriptive statistics are presented as

means and SD, and P < 0.05 was considered to be statistically significant.

FIGURE 1. Flowchart of data analyzed to evaluate the impact that behavioral
counseling training of primary care physicians has on reducing cardiovascular risk
factors in Ecuador

RESULTS

Source: Prepared by the authors from the study results.

Data were analyzed by simple, unadjusted comparisons, as well as by considering the clustered study design.
Since the outcome of both types of analyses were similar and the conclusions
were the same, only the results of the
unadjusted analysis are presented here.
The study period lasted from October
2014 – July 2016, with the 6-month
follow-up visits being held from April
2015 – July 2016. Initially, 1 397 patients
that met eligibility criteria (age and BMI)
were approached through a telephone
call (Figure 1). Of these, 1 172 were excluded because they declined to participate, did not come to the appointment,
were not accessible, or did not meet the
definitive eligibility criteria. The 225 patients who were eligible according to the
Stern formula were allocated to the ICG
(n = 125) and the UCG (n = 100). However, only 113 patients in the ICG and
84 in the UCG attended the baseline physician appointment. Of these, 99 patients
in the ICG and 63 in the UCG completed
the study (Figure 1).

4

Enrollment

Assessed for eligibility
(n = 1397)
Excluded (n = 1172)
Did not show for the visit (n = 611)
Not able to contact the patient (n = 463)
Not meeting inclusion criteria (n = 23)
Declined to participate (n = 41)
Other reasons (n = 34)
Randomized (n = 225)

Intervention care

Allocation

Usual care
Allocated to usual care (n = 100)
Received allocated care (n = 84)
Did not receive allocated care (n = 16)
Did not attend the appointment = 3
Not able to contact the patient = 6
Declined to participate = 4
Other reasons = 3

Allocated to intervention (n = 125)
Received allocated intervention (n = 113)
Did not receive allocated intervention (n = 12)
Did not attend the appointment = 9
Not able to contact the patient = 2
Declined to participate = 1
Follow-up

Lost to follow-up (n = 21)
Attended by different health provider = 1
Did not attend the appointment = 6
Not able to contact the patient = 2
Other = 3
Physician dropped the study = 9

Lost to follow-up (n = 12)
Attended by different health provider = 2
Did not attend the appointment = 7
Not able to contact the patient = 2
Other = 1
Analysis
Analyzed (n = 99)
Not able to draw sample = 1
Not attended to the appoinment = 1

Patient characteristics at baseline
A total of 197 patients were included
in the study, 138 (70%) women and
59 (30%) men. At baseline, ICG and
UCG were similar in age, gender, marital status, e mployment, family income,
and the proportion of first-degree relatives with type 2 diabetes. However,
educational level was higher in the
ICG (UCG 6±3.1 versus ICG 7.4±3.7;
P = 0.006). Also, at baseline both treatment groups were similar in clinical
and blood biochemical variables, except
for HbA1c which was higher in the ICG
(Table 1).

Physicians’ attitudes before and
after training
After counseling training, PCPs
scored significantly better in their attitudes toward providing advice on physical activity, diet, and lipid therapy

Analyzed (n = 63)

(from 14.5±4.1 to 11.0±2.1 in a reverse
scale; P < 0.05).

Feasibility of a patient-centered
counseling program
To evaluate patient perception of PCPs
regarding the behavioral counseling
intervention, a PEI was done after the
baseline visit. As expected, physicians in
the ICG delivered a significantly higher
number of counseling steps than those in
the UCG, 8.5±2.0 versus 6.1±2.6, respectively. Counseling steps regarding diet,
physical activity, and the prescription of
lipid-lowering medication were addressed significantly more often within
the ICG than the UCG (Table 2).

Changes in diet, physical activity,
and depression
Changes in healthy dietary behaviors
were recorded using the Block Dietary
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Fat Screener and Block Fruit/Vegetable
screeners (15); physical activity was
recorded using the Women’s Health

Original research

Initiative Physical Activity Questions
(17, 18). Patients in the ICG reduced the
amount of fat intake from baseline to the

TABLE 1. Baseline anthropometric and biological parameters of treatment groups in
a study of the impact that behavioral counseling training of primary care physicians
has on reducing cardiovascular risk factors in Ecuador
Demographic characteristicsa

Usual care group

Intervention group

P value

BMI (kg/m2)

31.8±4.8
(n = 83)

32.2±4.9
(n = 113)

0.596

Weight (kg)

79.8±14.2
(n = 83)

79.0±14.8
(n = 113)

0.710

SBP (mmHg)

122.2±13.5
(n = 83)

122.6±15.5
(n = 112)

0.850

DBP (mmHg)

79.4±11.2
(n = 83)

79.8±13.1
(n = 112)

0.826

Glucose (mg/dL)

104.1±22.9
(n = 84)

101.5±28.2
(n = 113)

0.495

HbA1C (%)

6.0±1.1
(n = 80)

6.4±1.3
(105)

0.023

TC (mg/dL)

206.6±34.0
(n = 84)

209.7±37.8
(n = 113)

0.553

LDL (mg/dL)

129.4±29.6
(n = 82)

129.0±30.6
(n = 105)

0.921

HDL (mg/dL)

43.0±10.6
(n = 84)

42.9±10.5
(n = 113)

0.968

TG (mg/dL)

178.9±94.8
(n = 84)

200.3±129.3
(n = 112)

0.201

Insulin

21.1±23.3
(n = 45)

18.6±10.1
(n = 83)

0.394

HOMA

5.7±8.8
(n = 45)

4.5±2.5
(n = 83)

0.246

end of the study, from a score of 17.2±7 to
14.3±7 (P = 0.005), while patients in the
UCG did not significantly change their
fat intake (P = 0.756). There were no significant differences in the consumption
of fruits and vegetables, either between
or within treatment groups. Regarding
physical activity, both treatment groups
presented a low-moderate physical activity, and this was comparable throughout the study period. In addition, at
baseline the prevalence of patients at
high risk for depression was higher in
the ICG than in the UCG (56.3% versus
32.9%; P = 0.001); however, this difference decreased by the end of the study
and was not statistically significant
(45.1% versus 33.9%).

Changes in anthropometric
parameters and blood pressure
Comparison between treatment groups
showed that there were no significant
differences in BMI and weight, at either
baseline or at the end of the study period.
However, as shown in Table 3, there was
a statistically significant decrease in BMI
and weight in both treatment groups
from baseline through the end of the
study period. The mean change was
greater in the ICG.
Blood pressures, both systolic and diastolic, were comparable between groups
at baseline and at the end of the study

BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure; HbA1C = glycosylated
hemoglobin; TC = total cholesterol; LDL = low-density lipoprotein-cholesterol; HDL = high-density lipoprotein-cholesterol;
TG = triglycerides; HOMA = Homeostasis Model Assessment.
Source: Prepared by the authors from the study results.
a

TABLE 2. Mean score of behavior counseling steps discussed by the primary care physician (PCP) according to the patient exit
interview (PEI), by treatment group, in a study of PCP training to reduce cardiovascular risk factors in Ecuador

Steps discussed or taken by the PCP

Overall (%)

Intervention care group

Usual care group

(%)

(%)

P valuea

1. Cholesterol

175/192 (91.1)

103/111 (92.8)

72/81 (88.9)

0.442

2. Diet-cholesterol connection

183/193 (94.8)

109/112 (97.3)

74/81 (91.4)

0.098

3. Recommended dietary change to lower cholesterol

176/192 (91.7)

107/111 (96.4)

69/81 (85.2)

0.007

4. Past efforts to lower cholesterol

100/189 (52.9)

76/111 (68.5)

24/78 (30.8)

0.000

5. Problems making dietary changes

92/187 (49.2)

62/109 (56.9)

30/78 (38.5)

0.017

6. Solutions to the problems

94/102 (92.2)

61/64 (95.3)

33/38 (86.8)

0.145

7. Made an agreement with patient on specific dietary changes or goals

169/190 (88.9)

103/110 (93.6)

66/80 (82.5)

0.019

8. Provided or sent nutrition materials to patient

126/192 (65.6)

109/112 (97.3)

17/80 (21.3)

0.000

22/192 (11.5)

11/111 (9.9)

11/81 (13.6)

0.494

10. Planned future visit to address cholesterol

127/193 (65.8)

81/112 (72.3)

46/81 (56.8)

0.031

11. Prescribed medication to lower cholesterol

34/193 (17.6)

28/112 (25.0)

6/81 (7.4)

0.000

12. Discussed beginning or continuing exercise

171/190 (90.0)

108/110 (98.2)

63/80 (78.8)

0.000

9. Referred patient for nutrition counseling

Group

No. of patients

Mean PEI score ±SD

Intervention care

113

8.5±2.0

Usual care
Total

84
197

6.1±2.6
7.5±2.5

P < 0.0001 (ANOVA).
Source: Prepared by the authors from the study results.
a
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period. However, in the UCG there was
a significant decrease in systolic blood
pressure from baseline until the end of
the study (Table 3).

Changes in blood biochemical
parameters
As indicated above, baseline comparison between treatment groups showed
that serum concentrations of HbA1c
were significantly lower in the UCG.
After 6 months of intervention, the CWI
was estimated; this CWI is the estimated
difference between ICG versus UCG according to the change in the measured
biochemical parameter. There were no

statistical differences in CWI for serum
glucose, direct LDL-C, HDL-C, triglycerides, and insulin between the groups.
However, there were statistically greater
decreases for HbA1c and Total-C in the
ICG than in the UCG.
Assessment of changes within groups
showed that in the UCG, only serum
concentrations of direct LDL-C significantly decreased from baseline to the
end of the study period ( -7mg/dL).
However, in the ICG there were significant decreases in serum concentrations of HbA1c, Total-C, and direct
LDL-C (
Table 4). Patients in the ICG
were significantly more likely to receive
lipid-lowering medications than the

UCG, 25.0% versus 7.4% respectively
(P = 0.001). In the ICG, 19 patients received statins and 6 received fibrates;
whereas in the UCG, none received statins, 5 received fibrates, and 1 received
an inhibitor of protein convertase subtilisin/kexin type 9. Further analysis considering only the individuals that did not
receive statin treatment showed that
patients in the ICG improved their serum
LDL concentrations from 125.8±26.1 to
122.0±33.0 (P = 0.001). However, patients
who did not receive statins in the UCG
decreased their serum LDL concentrations, from 127.7±30.7 to 121.0±30.4;
however, this decrease was not statistically significant, (P = 0.057).

TABLE 3. Changes in anthropometric parameters and blood pressure, by treatment group, at baseline and 24 weeks after the
intervention to reduce cardiovascular risk factors through behavioral counseling in Ecuador
Parametersa

Usual care group

Intervention care group

Baseline

Final

Mean change

P value

Baseline

Final

Mean change

P value

BMI

31.9±4.8
n = 54

31.6±4.9
n = 54

-0.36

0.035

32.5±5.1
n = 96

31.7±4.9
n = 96

-0.77

0.002b

Weight

80.0±14.0
n = 54

79.1±14.1
n = 54

-0.91

0.029

78.7±14.5
n = 96

76.9±14.4
n = 96

-1.79

0.005b

SBP

122.7±13.8
n = 58

118±9.7
n = 58

-4.64

0.024b

122.3±14.4
n = 97

120±16.9
n = 97

-2.26

0.215

DBP

78.9±11.2
n = 58

79±7.1
n = 58

+0.02

0.990

80.7±10.8
n = 98

78.8±14.3
n = 97

-1.9

0.262

BMI = body mass index; SBP = systolic blood pressure; DBP = diastolic blood pressure.
Statistically significant.
Source: Prepared by the authors from the study results.
a

b

TABLE 4. Comparison in blood biochemistry parameters, within treatment groups, at baseline and 24 weeks after the intervention
to reduce cardiovascular risk factors through behavioral counseling in Ecuador
Parametersa

Usual care group

Mean change

P value

97±16.8
n = 63

-3.27

5.9±1.1
n = 59

5.9±0.7
n = 59

TC

203.4±34.4
n = 63

LDL

Intervention care group

Mean change

P value

101.5±13.4
n = 92

-0.16

0.951

6.5±1.4
n = 81

5.8±0.5
n = 81

-0.72

0.000

0.129

210.1±38.1
n = 92

194.6±41.5
n = 92

-15.47

0.000

-6.98

0.033

129.7±29.9
n = 82

115.5±35.5
n = 82

-14.21

0.001

43.7±12.6
n = 63

+1,06

0.347

43.1±10.3
n = 91

42±11.2
n = 91

-1.11

0.165

171.3±95.5
n = 63

180.3±106.5
n = 63

+8.97

0.326

193.8±111.4
n = 91

181.1±105.4
n = 91

-12.65

0.136

Insulin

19.8±20.4
n = 61

25.9±29.4
n = 59

+6.1

0.667

18.7±9.9
n = 95

20.6±20.4
n = 71

+1.9

0.228

HOMA

5.3±7.6
n = 61

7.0±11
n = 59

+1.7

0.396

4.6±2.5
n = 95

5.4±6
n = 67

+0.8

0.305

Baseline

Final

Baseline

Final

Glucose

100.3±12.7
n = 63

0.087

101.7±30.9
n = 92

HbA1C

-0.04

0.772

198.1±33.5
n = 63

-5.29

126.7±29.9
n = 60

119.7±29.9
n = 60

HDL

42.6±10.5
n = 63

TG

HbA1C = glycosylated hemoglobin; TC = total cholesterol; LDL = low-density lipoprotein-cholesterol; HDL = high-density lipoprotein-cholesterol; TG = triglycerides; HOMA = Homeostasis
Model Assessment.
a
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Comparison of medication
compliance
Self-reported patient medication compliance was also evaluated. Results
showed that 98.3% of patients in the
ICG took medication as prescribed
5 – 7 days per week, while only 86.7% of
patients in the UCG did so in the same
period of time (P = 0.042).

DISCUSSION
This study demonstrated that it is
 ossible to implement an effective prop
gram to decrease CVD risk factors in
private and public primary care clinics
in Quito through an intervention of
physician-based, patient-centered counseling with office support. Most participating PCPs had a favorable attitude
towards the study. PCPs from the ICG
more frequently performed the counseling steps and followed the guidelines
to decrease CVD risk factors in their
patients. In a ddition, we observed that
patients in the ICG significantly decreased their fat consumption and risk
of depression, and improved their
weight, BMI, HbA1c, T
 otal-C, and direct
LDL-C.
Previous work has shown that lipid
management programs facilitated during physician visits result in a decrease
in CVD risk factors. Our previous work,
WATCH (7), in Massachusetts, evaluated the efficacy of an intervention
of physician-delivered patient-centered
counseling with office support, showing
significant beneficial changes in patient
diet, weight, and blood lipid levels after
1 year. In that study, patients attended
by physicians who had received the behavioral counseling training had lower
saturated fat intake (10.3% decrease), a
reduction in body weight (2.3 kg), and a
decrease in LDL-C (3.8 mg/dL). In the
present study, physician training plus
office support also resulted in reduced
fat intake and weight, similar to that
seen in the WATCH study; and the decrease in body weight (ICG -1.8 versus
UCG -0.91 kg/m2) also resulted in a significant BMI decrease, greater than that
observed by WATCH.
In addition, in the current study, patients in the ICG had lower blood
HbA1c, Total-C, and direct LDL-C by the
end of the intervention. A significant reduction of direct LDL-C was observed in

Rev Panam Salud Publica 42, 2018

the ICG regardless of statin use, although the reduction seen in those on
statins was greater. It is noticeable that
none of the subjects in the UCG received statins, although all subjects were
overweight or obese and were at risk of
developing diabetes. A study that assessed the use of effective therapies in
individuals with a history of coronary
heart disease or stroke in South America
showed that an important proportion
did not receive any proven therapy (19).
In the present study, we saw a similar
phenomenon in the UCG where statin
therapy was not used. Potential barriers
to treatment access in settings similar
to Ecuador include the high cost and
lack of medicines, and limited access to
health care and specialists; other variables affecting treatment adherence and
health care attendance are good communication and trust between patients and
physicians (6). Interventions to improve
physicians’ capacity to counsel patients
could contribute to closing the gaps in
the use of proven medications and improving health care provision.
Together, these results indicate that
implementation of an intervention of
physician-delivered, patient-centered
counseling with office support is feasible
in Ecuador, and that methodologies
originally developed for a United States
population are equally applicable to a
country on a different point of the socioeconomic continuum.
The current project was primarily a
feasibility study, and is in many ways
different from the larger WATCH study
(7). Fifteen physicians and 197 patients
from 4 different clinical systems participated in the present study, while 45
PCPs and 1 162 patients from 12 separate
patient care units were part of the
WATCH trial. In the WATCH study,
identification of an at-risk population
was determined by abnormal lipid profiles, while in the current report individuals with increased risk to develop
diabetes using the Stern estimation was
used as the inclusion criterion. The indicated eligibility criteria for both studies
could have resulted in a different profile
of patients regarding CVD risk factors.
The intervention lasted 6 months in the
present study and 1 year in the WATCH
study. However, physician training and
the components of the patient-centered
counseling model with office support
were similar for the two studies. These

Original research

two studies show that physician training
and the tools used are effective for decreasing CVD risk factors in at-risk populations. These results encourage the
implementation of larger studies with
similar intervention methodologies in
developing countries where cardiovascular diseases are major public health
problems.
Limitations. As indicated, this feasibility study was carried out with a limited number of PCPs and clinics that
could have specific administrative and
health care provision characteristics,
which could limit the generalizability of current results. Also, a follow up
of 6 months could be an insufficient
time to generate recommendations for
the implementation of this educational
intervention.

Conclusions
Training PCPs in a patient-centered
behavioral intervention for CVD risk factor reduction is feasible and efficacious.
The present intervention aligns with Alma-Ata principles that highlight the important role of a comprehensive primary
care strategy to improve public health
care. Implementation of this educational
strategy could be an important public
health measure to reduce cardiovascular
disease.
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RESUMEN

Repercusión de la
capacitación de médicos
de atención primaria
en orientación sobre el
comportamiento para reducir
los factores de riesgo
de sufrir enfermedades
cardiovasculares en Ecuador

Original research

Objetivo. Evaluar la factibilidad de implementar un modelo de intervención en el
médico y centrado en el paciente en Ecuador a fin de mejorar la capacidad de los médicos de atención primaria (MAP) para reducir los factores de riesgo de enfermedades
cardiovasculares (ECV) en los pacientes.
Métodos. Se llevó a cabo un ensayo clínico aleatorio en consultorios de atención primaria en Quito entre el 2014 y el 2016. Participaron 15 MAP y sus pacientes adultos
con riesgo alto de padecer diabetes de tipo 2. Se proporcionó un programa médico
orientativo centrado en el paciente a ocho MAP. Los siete que no recibieron la capacitación fueron el grupo testigo. Se evaluó la experiencia de los pacientes por medio de
una encuesta de salida a los pacientes. Se evaluaron las medidas antropométricas, la
presión arterial y los parámetros bioquímicos sanguíneos del paciente. Se calcularon
los cambios entre los grupos y dentro de ellos por medio de pruebas de ji cuadrado,
análisis de la varianza, pruebas t pareadas y coeficiente con intervención.
Resultados. En total participaron 197 pacientes, 113 en el grupo de atención con
intervención (GAI) y 84 en el grupo de atención habitual (GAH); 99 pacientes (87,6 %)
en el GAI y 63 (75 %) en el GAH completaron el estudio entre el 2014 y el 2016. Los
pasos de orientación, según los resultados de la encuesta de salida, fueron significativamente mayores en el GAI (8,9±1,6 frente a 6,6±2,3; P = 0,001). Al comparar la diferencia estimada entre el GAI y el GAH, se encontraron mayores reducciones de HbA1c
y del colesterol total en el GAI. Dentro del GAI, se encontraron mejoras considerables
en el peso, IMC, HbA1C, colesterol total y C-LDL.
Conclusiones. La capacitación de los MAP mediante una intervención sobre el comportamiento centrada en el paciente para reducir los factores de riesgo de ECV es factible y eficaz para reducir los factores de riesgo de ECV en Ecuador. Los países desarrollados y en desarrollo podrían beneficiarse por igual de tal intervención.

Palabras clave

Enfermedades cardiovasculares; capacitación de recursos humanos en salud; diabetes
mellitus tipo 2; HDL-colesterol; LDL-colesterol; presión sanguínea; Ecuador.

RESUMO

Objetivo. Avaliar a viabilidade de implementar um modelo de intervenção do tipo
orientação comportamental dirigida ao médico e centrada no paciente para melhorar
a capacidade dos profissionais da atenção primária de reduzir os fatores de risco de
doenças cardiovasculares nos pacientes.
Métodos. Estudo clínico randomizado conduzido em ambulatórios de atenção primária em Quito, no Equador, de 2014 a 2016. Participaram do estudo 15 médicos da
atenção primária e os respectivos pacientes adultos com alto risco de diabetes tipo 2.
Oito participantes fizeram parte de uma intervenção do tipo orientação comportamental dirigida ao médico e centrada no paciente. Os outros sete médicos fizeram
parte do grupo de controle que não recebeu a capacitação. A experiência do paciente
foi avaliada com uma entrevista de saída. Características antropométricas, medidas de
pressão arterial e parâmetros bioquímicos foram avaliados nos pacientes. As mudanças dentro de um mesmo grupo e entre os grupos foram estimadas com o uso do teste
do qui-quadrado, ANOVA, teste t pareado e coeficiente com intervenção.
Resultados. Participaram do estudo 197 pacientes ao todo, sendo 113 no grupo de
intervenção (GI) e 84 no grupo de atenção de rotina (GR), e completaram o estudo 99
pacientes (87,6%) no GI e 63 (75%) no GR em 2014–2016. O GI recebeu um número
significativamente maior (8.9±1.6 vs. 6.6±2.3; P = 0.001) de orientações, avaliadas na
entrevista de saída. Uma comparação da diferença estimada entre o GI e o GR demonstrou maior redução no nível de hemoglobina glicosilada (HbA1c) e colesterol total no
GI. Os pacientes do GI tiveram melhora significativa no peso corporal, índice de massa
corporal (IMC), colesterol total e LDL.
Conclusões. Capacitar os médicos da atenção primária em uma intervenção comportamental centrada no paciente é uma opção viável e eficaz para reduzir os fatores de
risco de doenças cardiovasculares no Equador. Ambos os países desenvolvidos e em
desenvolvimento poderiam se beneficiar com esta intervenção.

Impacto da capacitação
de médicos da atenção
primária em orientação
comportamental para
reduzir os fatores de
risco de doenças
cardiovasculares no
Equador

Palavras-chave
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Doenças cardiovasculares; capacitação de recursos humanos em saúde; diabetes mellitus tipo 2; HDL-colesterol; LDL-colesterol; pressão sanguínea; Equador.
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